G. Giovannoni et al., RAISED SERUM NITRATE AND NITRITE LEVELS IN PATIENTS WITH MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 145(1), 1997, pp. 77-81
Nitric oxide and its highly reactive derivative peroxynitrite have bee
n implicated as non-specific inflammatory mediators of neuronal and ol
igodendrocyte damage and death in multiple sclerosis. In a cross-secti
onal study we found levels of the nitric oxide metabolites nitrate and
nitrite to be raised in the serum of patients with demyelinating dise
ase (65.6 mu M (SD 32.9)), acquired immune deficiency syndrome (57.9 m
u M (SD 34.9)) and inflammatory neurological disease (57.5 mu M (SD 31
.3)), compared with normal control subjects (32.8 mu M (SD 12.2)) and
patients with non-inflammatory neurological disease (41.1 mu M (SD 12.
3), p < 0.001). Nitric oxide metabolites were raised in all clinical s
ubtypes of multiple sclerosis, as well as in clinically isolated syndr
omes compatible with demyelination, and related to progressive disease
or disability. This study provides further evidence for a role of nit
ric oxide in the immunopathogenesis of inflammatory diseases of the ce
ntral nervous system, including multiple sclerosis. (C) 1997 Elsevier
Science B.V.